drugset / Trial / NCT05505123
Sevoflurane and Propofol for Botulinum Toxin Injection
Withdrawn
Yeungnam University College of Medicine
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigators would like to compare clinical features (onset, duration, emergence time), efficacy of deep sedation (successful completion of procedure), safety (adverse events) and caregiver's satisfaction for sedation when used propofol and sevoluflurane for deep sedation in 3-11 year old pediatric patients with spastic cerebral palsy receiving botulinum toxin injection.
Timeline
- Start
- 2022-08-26
- Primary completion
- 2022-12-09
- Completion
- 2022-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propofol | Small molecule | — | Intravenous |
| Subject | Sevoflurane | Other / unclassified | — | Inhaled |